Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex

Authors:

Abstract
DHTKD1 is the E1 component of the 2-oxoadipate dehydrogenase complex, an enzyme involved in the catabolism of (hydroxy-)lysine and tryptophan. Mutations in DHTKD1 have been associated with 2-aminoadipic and 2-oxoadipic aciduria, Charcot-Marie-Tooth disease type 2Q and eosinophilic esophagitis, but the pathophysiology of these clinically distinct disorders remains elusive. Here we report the identification of adipoylphosphonic acid and tenatoprazole as DHTKD1 inhibitors using targeted and high throughput screening, respectively. We furthermore elucidate the DHTKD1 crystal structure with thiamin diphosphate bound at 2.25 Å. We also report the impact of ten disease-associated missense mutations on DHTKD1. Whereas the majority of the DHTKD1 variants displayed impaired folding or reduced thermal stability in combination with absent or reduced enzyme activity, three variants showed no abnormalities. Our work provides chemical and structural tools for further understanding of the function of DHTKD1 and its role in several human pathologies.
All Related Versions
Funding Information
  • U.S. Department of Health and Human Services (UL1TR001433)
  • U.S. Department of Energy (KP1605010)
  • U.S. Department of Health and Human Services (P41GM111244, R35GM124838)
  • U.S. Department of Health and Human Services (R03HD092878, R21HD088775)

This publication has 31 references indexed in Scilit: